Type of follow-up required for the general medical findings
| Total conditions | Further investigations | Treatment | Prevention recommendation | Repeat examination | |
|---|---|---|---|---|---|
| n | n | n | n | n | |
| Vitamin D | 499 | – | 496 | 3 | 0 |
| Hepatitis B | 164 | 4* | 160 | 0 | 0 |
| Lipids | 59 | – | – | 47 | 12 |
| Iron deficiency/anaemia | 56 | 9 | 38 | 7 | 2 |
| CBC alterations (other) | 42 | 24 | – | 1 | 17 |
| Vision | 38 | 29 | – | 9 | 0 |
| Urological | 36 | 2 | – | 3 | 31 |
| Endocrine/metabolic | 12 | – | 1 | 1 | 10 |
| Pulmonary | 12 | 8 | 2 | 1 | 1 |
| Ear, nose and throat (ENT) | 3 | 3 | – | – | – |
| Infective/immunology (other) | 2 | 1 | – | – | 1 |
| Dermatological | 2 | 1 | – | 1 | – |
| Neurological | 2 | 1 | 1 | – | – |
| Other | 6 | 1 | – | 4 | 1 |
| Total | 933 | 83 | 698 | 77 | 75 |
*Hepatitis B, 4 of the players were seropositive. Three of the 4 were chronic carriers under long-term follow-up (one was lost to follow-up) with normal or near normal liver function tests, whereas 1 was core antibody positive following previous infection.